NDC11 60505056403
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 60505-0564-03 | 60505-0564 |
| 60505-0564-3 | 60505-0564 |
| 60505-564-03 | 60505-564 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Brimonidine Tartrate | BRIMONIDINE TARTRATE | Apotex Corp. | 64b21e68-610c-5194-ccb2-9d9f6ff8cda9 | 2025-10-08 | Warnings, Adverse reactions | 60505-0564-3 60505-0564 60505056403 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.